Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Shares Outstanding (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Shares Outstanding for 4 consecutive years, with $71.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 4.23% to $71.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $71.4 million through Dec 2025, up 4.23% year-over-year, with the annual reading at $71.4 million for FY2025, 4.23% up from the prior year.
  • Shares Outstanding for Q4 2025 was $71.4 million at Phathom Pharmaceuticals, up from $71.0 million in the prior quarter.
  • The five-year high for Shares Outstanding was $71.4 million in Q4 2025, with the low at $19.0 in Q1 2023.
  • Average Shares Outstanding over 4 years is $54.2 million, with a median of $58.2 million recorded in 2023.
  • The sharpest move saw Shares Outstanding surged 47.6% in 2023, then rose 3.46% in 2024.
  • Over 4 years, Shares Outstanding stood at $41.5 million in 2022, then soared by 39.79% to $58.0 million in 2023, then increased by 18.2% to $68.5 million in 2024, then increased by 4.23% to $71.4 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $71.4 million, $71.0 million, and $70.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.